GRIFFIN MICHELLE RENEE sold 49.6% of their position (15.39K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $214.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2026ACC: 0001229765-26-000006
Director
Since Jun 2019
-15.39K
Net shares
Net seller
$214.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15.39K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.39K
Price / share
$13.91
Trade value
$214.13K
% of position
49.6%
3/11/2026
31.02K→15.63K
Total
Net shares
−15.39K
Net value
-$214.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −15.39K | $13.91 | $214.13K | 49.6% | 31.02K | 15.63K |
| Total | −15.39K | -$214.13K | ||||||
Derivative Transactions0
No derivative transactions reported